S&P 500

5.222,68

0,16%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Achieve Life Sciences Inc (ACHV)
Achieve Life Sciences Inc (ACHV) Notícias

ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ACHV

1 2 3 4 5 6 7 8 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
09/05/2024	17:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACHV	Achieve Life Sciences Inc
09/05/2024	17:01	GlobeNewswire Inc.	Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update	NASDAQ:ACHV	Achieve Life Sciences Inc
07/05/2024	01:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACHV	Achieve Life Sciences Inc
06/05/2024	12:16	GlobeNewswire Inc.	Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine	NASDAQ:ACHV	Achieve Life Sciences Inc
25/04/2024	09:00	GlobeNewswire Inc.	Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024	NASDAQ:ACHV	Achieve Life Sciences Inc
11/04/2024	09:00	GlobeNewswire Inc.	Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference	NASDAQ:ACHV	Achieve Life Sciences Inc
28/03/2024	17:01	GlobeNewswire Inc.	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update	NASDAQ:ACHV	Achieve Life Sciences Inc
20/03/2024	09:00	GlobeNewswire Inc.	Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting	NASDAQ:ACHV	Achieve Life Sciences Inc
14/03/2024	09:00	GlobeNewswire Inc.	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024	NASDAQ:ACHV	Achieve Life Sciences Inc
06/03/2024	18:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
29/02/2024	18:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACHV	Achieve Life Sciences Inc
29/02/2024	18:16	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ACHV	Achieve Life Sciences Inc
29/02/2024	10:01	GlobeNewswire Inc.	Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission	NASDAQ:ACHV	Achieve Life Sciences Inc
29/02/2024	10:00	GlobeNewswire Inc.	Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement	NASDAQ:ACHV	Achieve Life Sciences Inc
27/02/2024	17:32	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ACHV	Achieve Life Sciences Inc
09/11/2023	18:00	GlobeNewswire Inc.	Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update	NASDAQ:ACHV	Achieve Life Sciences Inc
26/10/2023	09:00	GlobeNewswire Inc.	Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023	NASDAQ:ACHV	Achieve Life Sciences Inc
03/10/2023	09:00	GlobeNewswire Inc.	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	NASDAQ:ACHV	Achieve Life Sciences Inc
11/09/2023	09:00	GlobeNewswire Inc.	Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting	NASDAQ:ACHV	Achieve Life Sciences Inc
14/08/2023	17:00	GlobeNewswire Inc.	Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update	NASDAQ:ACHV	Achieve Life Sciences Inc
01/08/2023	09:00	GlobeNewswire Inc.	Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast	NASDAQ:ACHV	Achieve Life Sciences Inc
18/07/2023	09:00	GlobeNewswire Inc.	Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting	NASDAQ:ACHV	Achieve Life Sciences Inc
11/07/2023	12:23	GlobeNewswire Inc.	Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)	NASDAQ:ACHV	Achieve Life Sciences Inc
26/06/2023	07:02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ACHV	Achieve Life Sciences Inc
09/06/2023	17:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACHV	Achieve Life Sciences Inc
09/06/2023	17:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACHV	Achieve Life Sciences Inc
25/05/2023	17:07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ACHV	Achieve Life Sciences Inc
25/05/2023	10:00	GlobeNewswire Inc.	Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering	NASDAQ:ACHV	Achieve Life Sciences Inc
23/05/2023	07:00	GlobeNewswire Inc.	Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial	NASDAQ:ACHV	Achieve Life Sciences Inc
17/05/2023	09:00	GlobeNewswire Inc.	Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank	NASDAQ:ACHV	Achieve Life Sciences Inc